Growth Hormone Secretagogues for Men: What to Know
Written by the Innovative Men's Health Editorial Team
Medically reviewed by Alessa Lopez-Castor, ARNP, DNP
Last medically reviewed: September 17, 2026
Important regulatory note: Online ads for growth hormone secretagogues, sermorelin for men, GHRH analogs, and GHRP-type agents often sound like wellness shortcuts. Adult growth hormone deficiency (GHD) is a clinical diagnosis that typically requires specialist evaluation—not a shopping category for fatigue, age, or body-composition goals.
Many products marketed as secretagogues are not FDA-approved for anti-aging, fat loss, muscle, or sexual-wellness claims. Compounded drugs are not FDA-approved, and FDA does not verify their safety, effectiveness, or quality before marketing. This article is educational only. It does not teach dosing, reconstitution, stacking, sourcing, or self-injection. An inquiry is not a prescription.
What growth hormone secretagogues means
Growth hormone secretagogues are agents discussed for stimulating the body's own growth hormone release rather than replacing GH with recombinant human growth hormone. Marketing often places several different categories under the same umbrella.
GHRH analogs: growth hormone-releasing hormone-related compounds; sermorelin is historically discussed in this group.
GHRP-type or ghrelin-pathway agents: names such as ipamorelin and CJC-type combinations commonly appear in online marketing. Naming them here does not endorse their use.
That distinction may help readers understand advertisements, but it is not a treatment protocol or product recommendation. Labeled care pathways for diagnosed adult GHD generally center on clinician-directed growth hormone therapy after appropriate evaluation. Online secretagogue marketing frequently differs from those pathways.
Adult GHD is a diagnosis—not an anti-aging catalog
Adult growth hormone deficiency may persist from childhood or be acquired later, such as in the setting of pituitary disease, structural lesions, cranial irradiation, or other specialist-defined risks. Confirmation through stimulation testing is generally required unless a proven genetic or structural condition establishes the diagnosis.
Idiopathic adult GHD is rare, and stringent criteria matter because false-positive stimulation-test results can occur when the clinical context does not support testing. A normal IGF-1 level does not necessarily exclude GHD, while a low level may support concern but does not replace a thoughtful evaluation.
Nonspecific fatigue, slower recovery, aging concerns, or interest in optimization are not the same as diagnosed adult GHD. Treatment decisions require individualized assessment of potential benefits and risks.
Names you may see online—without protocols
Sermorelin
Sermorelin is historically discussed as a GHRH analog. Historical U.S. branded products were withdrawn from commercial marketing for business reasons years ago. That history does not create FDA approval for modern anti-aging, performance, or body-composition claims. Compounding availability is also not the same as an FDA-approved wellness indication.
Ipamorelin and CJC-type marketing
Ipamorelin and CJC-type products are common examples in online GHRP and related marketing. Claims about anti-aging, muscle gain, fat loss, energy, or sexual performance are not FDA-approved wellness indications.
The labeled contrast
Some related medicines have narrow, specific labeled uses. Other agents, such as macimorelin, have an FDA-approved diagnostic role in adult GHD testing. A specific labeled indication does not validate a broad online wellness catalog.
If an advertisement promises anti-aging, fat loss, muscle gain, or sexual results from a research or compounded secretagogue, treat it as marketing—not as a diagnosis.
FDA compounding and unapproved-peptide concerns
FDA states that compounded drugs are not FDA-approved and are not reviewed for safety, effectiveness, or quality before marketing. Compounding can serve an important need when an FDA-approved medicine is not medically appropriate for a particular patient, but unnecessary use can introduce serious quality and safety risks.
FDA has identified potential significant safety risks involving several GH-related bulk substances proposed for compounding. Its current materials discuss GHRP-2, GHRP-6, ipamorelin acetate, and CJC-1295, including concerns involving immunogenicity, peptide-related impurities, limited safety information, and reported serious adverse events. These warnings reinforce why research-use products and unregulated online sourcing are not appropriate substitutes for medical care.
What an evaluation-first visit may cover
A no-pressure consultation is a medical evaluation, not a product tour. A clinician may review pituitary disease, prior GH deficiency, cranial irradiation, head trauma, other hormone deficiencies, medications, symptoms, and the clinical likelihood of adult GHD.
Testing may include IGF-1 and, when appropriate, specialist-directed stimulation testing interpreted in clinical context—not a DIY kit. Shared decision-making should address risks, FDA status, alternatives, and the uncertainty associated with unregulated products, including unknown potency, contamination, mislabeling, and immunogenicity.
A visit may conclude with education, lifestyle priorities, additional endocrine workup, an FDA-approved pathway when appropriate, or a finding that treatment is not indicated. Low-testosterone symptoms are evaluated separately and are not evidence of a secretagogue need.
Care at IMHS Bellevue and Washington telehealth
Innovative Men's Health offers evaluation-first care at 1940 116th Ave NE Unit 201, Bellevue, WA 98004. Call (425) 455-1700. Eligible Washington adults may use telehealth when clinically appropriate. Evaluation is required, treatment is individualized, and results vary.
Key takeaways
Growth hormone secretagogues are marketed as stimulators of endogenous GH release, but online claims often differ from labeled medical pathways.
Sermorelin is historically discussed as a GHRH analog; ipamorelin and CJC-type names commonly appear in online marketing. Naming them is not an endorsement.
Adult GHD is a clinical diagnosis that usually requires specialist evaluation and stimulation testing.
Compounded drugs are not FDA-approved, and FDA has flagged safety concerns involving several GH-related bulk peptides.
This article does not promote HGH or secretagogues for anti-aging wellness and provides no dosing, reconstitution, or stacking instructions.
A consultation provides evaluation and education; it does not guarantee a prescription or outcome.
Frequently asked questions
What are growth hormone secretagogues?
They are agents discussed for stimulating endogenous growth hormone release. Consumer marketing often mixes GHRH-analog and GHRP-type products under the same label, but that does not create an FDA-approved wellness indication.
Is sermorelin for men an FDA-approved anti-aging treatment?
No. This article does not promote sermorelin or any secretagogue for anti-aging wellness. Adult GHD is evaluated in an appropriate clinical context.
How is adult GHD diagnosed?
Evaluation begins with clinical likelihood and relevant history. In most cases, confirmatory stimulation testing is required. Optimization interest alone is not a diagnosis.
Are compounded GH peptides the same as FDA-approved GH therapy?
No. Compounded drugs are not FDA-approved. Clinician-directed labeled GH therapy for diagnosed adult GHD differs from many online secretagogue catalogs.
Will a consultation guarantee a secretagogue or HGH prescription?
No. A consultation provides evaluation and education. It does not guarantee a prescription or any anti-aging, body-composition, energy, or sexual outcome.
Take the next step
Sources
Disclaimer
This article is for educational purposes only and does not provide medical advice, diagnosis, or treatment or establish a provider-patient relationship. Adult GHD is a clinical diagnosis requiring appropriate medical evaluation. Innovative Men's Health does not diagnose readers from this page and does not guarantee anti-aging, fat-loss, muscle, energy, sexual, or other outcomes. This page does not teach dosing, reconstitution, stacking, sourcing, or self-injection and does not promote HGH or secretagogues for anti-aging wellness. Evaluation is required; treatment is individualized; inquiry does not guarantee a prescription; results vary. For emergencies, call 911.
Comments